Innovative Toxicity Assays of Pollutants, Therapeutics, and Drugs (SBIR [R43/R44])

The summary for the Innovative Toxicity Assays of Pollutants, Therapeutics, and Drugs (SBIR [R43/R44]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Innovative Toxicity Assays of Pollutants, Therapeutics, and Drugs (SBIR [R43/R44]): -Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms.
Federal Grant Title: Innovative Toxicity Assays of Pollutants, Therapeutics, and Drugs (SBIR [R43/R44])
Federal Agency Name: National Institutes of Health
Grant Categories: Education Environment Food and Nutrition Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-09-006
Type of Funding: Grant
CFDA Numbers: 93.113
CFDA Descriptions: Environmental Health
Current Application Deadline: Sep 07, 2009
Original Application Deadline: Sep 07, 2009
Posted Date: Oct 07, 2008
Creation Date: Jan 26, 2009
Archive Date: Oct 08, 2009
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) ...
Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 ...
BRAIN Initiative: Marmoset Colonies for Neuroscience Research (U24 Clinical Trials Not All...
BRAIN Initiative: Marmoset Coordination Center (U24 Clinical Trials Not Allowed)
Undergraduate Research Education Program (UP) to Enhance Diversity in the Environmental He...
Outstanding New Environmental Scientist Award (ONES)
Environmental Health Sciences Core Center Grants
Leiomyomata Uteri: Basic Science and Translational Research
More Grants from the National Institutes of Health
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinica...
NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com